Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

28.60
Delayed Data
As of Feb 05
 -4.01 / -12.30%
Today’s Change
18.50
Today|||52-Week Range
60.79
-46.83%
Year-to-Date

Today’s Trading

Previous close32.61
Today’s open32.11
Day’s range28.52 - 32.60
Volume619,240
Average volume (3 months)545,358
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+31.41%
Earnings growth (this year)-192.92%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.91%
P/E ratioNM
Price/Sales875.93
Price/Book7.00

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.35-5.19%
IRWDIronwood Pharmaceuti...-0.65-7.16%
INSYINSYS Therapeutics I...-0.27-1.63%
PBYIPuma Biotechnology I...-4.26-9.69%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$577.3K
Annual profit (last year)-$30.7M
Net profit margin-5,316.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers